… Although chemotherapy has been the backbone therapy for advanced gastric cancer for … to
be the standard first-line therapy for HER2-positive gastric cancer. The anti-VEGFR2 inhibitor, …

… is the combination of neoadjuvant chemoradiotherapy, molecular-targeted therapy, and …
treat advanced gastric cancer and discuss the progress made in the treatment of gastric cancer …

… of gastric cancer is expected to … advanced gastric cancer remains poor. In this review we
discuss current standards of care and outline major topics of drug development in gastric cancer…

… for the treatment of advanced gastric cancer (AGC). The anti-… efficacy for HER2-positive breast
cancer. The efficacy of the … gastric cancer is a milestone for antiangiogenic therapy for AGC…

… The treatment of patients with advanced gastric cancer remains a challenging area of
oncology. Extensive trials of differing chemotherapy regimens have yielded no international …

The systemic treatment options for advanced gastric cancer (GC) have evolved rapidly in
recent years. We have reviewed the recent data of clinical trial incorporating targeted agents, …

… advanced gastric cancer have to consider more than just the potential benefit of CT. Patients
with advanced gastric cancer … questions in the management of advanced gastric carcinoma. …

… Local progression of advanced gastric cancer often manifests as bleeding, dysphagia/…
From 1996 to 2004, 37 gastric cancer patients were treated with palliative RT (median dose …

… at advanced stages and have a poor prognosis. Though first-line chemotherapy for advanced
gastric cancer (AGC… The median survival of advanced gastric cancer patients who received …

… There is uncertainty about the effect of adding targeted therapy to chemotherapy on survival
outcomes in people with advanced gastric cancer, with very little information on its impact on …